77 related articles for article (PubMed ID: 8801743)
1. [Nitroxyl radical Tempol as a modulator of toxic and antineoplastic effect of 6-mercaptopurine].
Konovalova NP; D'iachkovskaia RF; Volkova LM; Varfolomeev VN
Vopr Onkol; 1996; 42(3):57-63. PubMed ID: 8801743
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of tempol on toxicity and antitumor activity of 6-mercaptopurine and on P450 cytochrome level.
Konovalova NP; Diatchkovskaya RF; Volkova LM; Varfolomeev VN
Neoplasma; 1996; 43(5):341-6. PubMed ID: 8996555
[TBL] [Abstract][Full Text] [Related]
3. Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model.
Kaledin VI; Popova NA; Nikolin VP; Vasilieva ED; Kirilyuk IA; Grigor'ev IA
Free Radic Res; 2009 Jul; 43(7):685-90. PubMed ID: 19526393
[TBL] [Abstract][Full Text] [Related]
4. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
Gadjeva V; Lazarova G; Zheleva A
Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
[TBL] [Abstract][Full Text] [Related]
5. [Nitroxyl radicals--modifiers of the toxic action of cytostatics].
Konovalova NP
Vopr Onkol; 1995; 41(2):49-50. PubMed ID: 7483434
[No Abstract] [Full Text] [Related]
6. Nitroxyl radicals for labeling of conventional therapeutics and noninvasive magnetic resonance imaging of their permeability for blood-brain barrier: relationship between structure, blood clearance, and MRI signal dynamic in the brain.
Zhelev Z; Bakalova R; Aoki I; Matsumoto K; Gadjeva V; Anzai K; Kanno I
Mol Pharm; 2009; 6(2):504-12. PubMed ID: 19718801
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive treatment of murine neuroblastoma with 6-hydroxydopamine and Tempol.
Purpura P; Westman L; Will P; Eidelman A; Kagan VE; Osipov AN; Schor NF
Cancer Res; 1996 May; 56(10):2336-42. PubMed ID: 8625308
[TBL] [Abstract][Full Text] [Related]
8. Tempol, one of nitroxides, is a novel ultraviolet-A1 radiation protector for human dermal fibroblasts.
Yan SX; Hong XY; Hu Y; Liao KH
J Dermatol Sci; 2005 Mar; 37(3):137-43. PubMed ID: 15734282
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of TEMPOL in central and peripheral nervous system models of Parkinson's disease.
Liang Q; Smith AD; Pan S; Tyurin VA; Kagan VE; Hastings TG; Schor NF
Biochem Pharmacol; 2005 Nov; 70(9):1371-81. PubMed ID: 16144694
[TBL] [Abstract][Full Text] [Related]
10. Prevention of catecholaminergic oxidative toxicity by 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl and its recycling complex with polynitroxylated albumin, TEMPOL/PNA.
Weinberg A; Nylander KD; Yan C; Ma L; Hsia CJ; Tyurin VA; Kagan VE; Schor NF
Brain Res; 2004 Jun; 1012(1-2):13-21. PubMed ID: 15158156
[TBL] [Abstract][Full Text] [Related]
11. Formation of TEMPOL-hydroxylamine during reaction between TEMPOL and hydroxyl radical: HPLC/ECD study.
Kudo W; Yamato M; Yamada K; Kinoshita Y; Shiba T; Watanabe T; Utsumi H
Free Radic Res; 2008 May; 42(5):505-12. PubMed ID: 18484414
[TBL] [Abstract][Full Text] [Related]
12. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney.
Enli Y; Oztekin O; Pinarbasili RD
Scand J Clin Lab Invest; 2009; 69(4):526-34. PubMed ID: 19343575
[TBL] [Abstract][Full Text] [Related]
13. Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension.
Stec DE; Juncos LA; Granger JP
J Am Soc Hypertens; 2016 Apr; 10(4):346-51. PubMed ID: 26922123
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative effect of the piperidine nitroxide TEMPOL on neoplastic and nonneoplastic mammalian cell lines.
Gariboldi MB; Lucchi S; Caserini C; Supino R; Oliva C; Monti E
Free Radic Biol Med; 1998 Apr; 24(6):913-23. PubMed ID: 9607601
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant Drug Tempol Promotes Functional Metabolic Changes in the Gut Microbiota.
Cai J; Zhang L; Jones RA; Correll JB; Hatzakis E; Smith PB; Gonzalez FJ; Patterson AD
J Proteome Res; 2016 Feb; 15(2):563-71. PubMed ID: 26696396
[TBL] [Abstract][Full Text] [Related]
16. Small volume resuscitation with tempol is detrimental during uncontrolled hemorrhagic shock in rats.
Kentner R; Safar P; Behringer W; Wu X; Henchir J; Ma L; Hsia CJ; Tisherman SA
Resuscitation; 2007 Feb; 72(2):295-305. PubMed ID: 17112648
[TBL] [Abstract][Full Text] [Related]
17. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
[TBL] [Abstract][Full Text] [Related]
18. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo.
Ritchie RH; Quinn JM; Cao AH; Drummond GR; Kaye DM; Favaloro JM; Proietto J; Delbridge LM
J Mol Cell Cardiol; 2007 Jun; 42(6):1119-28. PubMed ID: 17490678
[TBL] [Abstract][Full Text] [Related]
19. Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia.
Hoffmann DS; Weydert CJ; Lazartigues E; Kutschke WJ; Kienzle MF; Leach JE; Sharma JA; Sharma RV; Davisson RL
Hypertension; 2008 Apr; 51(4):1058-65. PubMed ID: 18259014
[TBL] [Abstract][Full Text] [Related]
20. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization.
Numa R; Kohen R; Poltyrev T; Yaka R
Neuroscience; 2008 Aug; 155(3):649-58. PubMed ID: 18619523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
